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B. Baslya, D. Felder-Flescha, P. Perriatb, G. Pourroya and S. Be´gin-Colina*Functionalized iron oxide nanoparticles have attracteContrast Md an increasing interest in the last 10 years as contrast agents for
MRI. One challenge is to obtain homogeneous and stable aqueous suspensions of iron oxide nanoparticles without
aggregates. Iron oxide nanoparticles with sizes around 10nm were synthesized by two methods: the particle size
distribution in water suspension of iron oxide nanoparticles synthesized by the co-precipitation method was
improved by a process involving two steps of ligand exchange and phase transfer and was compared with that
of iron oxide nanoparticles synthesized by thermal decomposition and functionalized by the same dendritic molecule.
The saturation magnetization of dendronized nanoparticles synthesized by thermal decomposition was lower than
that of nanoparticles synthesized by co-precipitation. The r2 relaxivity values were shown to decrease with the
agglomeration state in suspension and high r2 values and r2/r1 ratios were obtainedwith nanoparticles synthesized by
co-precipitation by comparison with those of commercial products. Dendronized iron oxide nanoparticles thus have
potential properties as contrast agent. Copyright # 2010 John Wiley & Sons, Ltd.
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Superparamagnetic iron oxide nanoparticles (SPION) with
appropriate surface coatings (1–6) are widely used for numerous
in vivo applications such as MRI contrast enhancement (7–10),
hyperthermia treatment (11,12), cell sorting (13), drug delivery,
immunoassay and tissue repair (14–16). In the biomedical field,
most work has been performed to improve the materials’
biocompatibility and targeting (17), but only a few investigations
and developments have been carried out to improve the quality
of the magnetic nanoparticles (NPs), their size distribution and
studying the effect of their functionalization on their structural
and magnetic properties.
Indeed, high-quality iron oxide NPs with controlled size have to
be synthesized as the magnetic properties strongly depend on
the nanoparticle size and since biomedical applications require
not only high saturation magnetization values but also particle
sizes smaller than 100 nm and a narrow particle size distribution
in suspension (18–23). The suspension stability depends strongly
on the organic coating. Also, recent studies have demonstrated
that modification of the surface by an organic coating may
influence the final magnetic properties of the functionalized NPs
depending on the coupling agent (24–28). Moreover, this coating
should ensure biocompatibility and biodistribution and allow
targeting specific areas (17,18,23).
For biological applications, dendrimers and especially the
so-called ‘dendron’ building blocks are very promising as the
diversity of functionalization brought by the arborescent
structure simultaneously solves the problems of biocompatibility,
low toxicity, large in vivo stability and specificity. Moreover, in
addition to the multifunctionalization of a low molecular weightedia Mol. Imaging 2011, 6 132–138 Copyrighmolecule, the arborescent monodisperse building blocks allow a
versatility and a control of size (according to the generation) and
of physicochemical properties (hydrophilic, lipophilic) (29). The
resulting effects on stability (dendrimer effect), contrast qualities,
pharmacokinetics and biodistribution of the contrast agents can
clearly be identified. We already described dendron anchoring at
the surface of NPs synthesized by coprecipitation and showed
that such design allows preserving the magnetic properties while
minimizing the thickness of the organic shell necessary for a
good colloidal stabilization (24,30,31).
Iron oxide nanoparticles have been synthesized by numerous
methods (21,32–35) but the most reported and easy one is
the co-precipitation method which occurs in water and leads to
nanoparticles with sizes in the range 5–40 nm (36,37). However,
the NPs are quite aggregated in water suspension after the
synthetic step and the direct functionalization does not greatly
improve the particle size distribution. Another recent method is
the thermal decomposition of iron complex, such as Fe(CO)5, iron
oleate and iron acetylacetonate, in high boiling point solvent,t # 2010 John Wiley & Sons, Ltd.
Figure 1. Structure of the dendron.
DENDRONIZED IRON OXIDE NANOPARTICLES FOR MRI APPLICATIONSwhich leads to monodisperse iron oxide nanoparticles coated by
fatty acid and forming very stable andmonodisperse suspensions
in organic solvents (34,38). Water suspensions of these decorated
NPs are obtained by a ligand exchange process with a hydrophilicFigure 2. TEM micrographs of iron oxide NPs synthesized by co-precipitati
Figure 3. Zeta potential measurements as a function of pH of stripped N
synthesized by co-precipitation and functionalized either directly (NPcop@MO
thermal decomposition and functionalized by ligand exchange and phase t
Contrast Media Mol. Imaging 2011, 6 132–138 Copyright # 2010 Johmolecule (21). Moreover NPs synthesized by thermal decompo-
sition are reported to display higher cristallinity and thus
higher magnetic properties due to a synthetic process at high
temperature (21,39).
In this work, iron oxide NPs were synthesized by co-
precipitation (NPcop) and by thermal decomposition of an iron
stearate complex (NPtd). Both these NPs are covalently coated
with a hydrophilic oligoethyleneglycol-based dendron displaying
a phosphonic acid at the focal point (Fig. 1). The suspension
stability of the NPcop is improved by a process involving
two steps of ligand exchange, and the magnetic properties of all
NPs are compared before and after decoration and relaxivity
measurement are discussed.2. Results and discussion
Iron oxide NPs with sizes around 10 nm (Fig. 2) were synthesized
by two methods: the co-precipitation of iron chlorides by a base
(36) and the thermal decomposition of an iron stearate complex.
X-ray and electron diffraction showed that both nanoparticles
display the typical spinel structure. The value of the lattice
parameter a¼ 0.8383 nm and a¼ 0.8384 nm calculated from
XRD patterns for NPcop and NPtd, respectively, is intermediateon (left) and by thermal decomposition (right).
Ps synthesized by coprecipitation (NPcop), dendronized iron oxide NPs
L) or by a two-step process (NPcop@MOL-LE), and of NPs synthesized by
ransfer (NPtd@MOL).
n Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/cmmi
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Figure 4. Particle size distribution in water suspension at pH¼ 6.8 of
iron oxide NPs synthesized by co-precipitation before and after direct
functionalization (a); after oleic acid coating (NPcop@OA) and after the
ligand exchange step (NPcop@MOL-LE) (b); and of NPs synthesized by
thermal decomposition before and after the ligand exchange step (c).
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4between those of magnetite (0.8396 nm, JCPDS file 19-629) and
maghemite (0.8346 nm, JCPDS file 39-1346), meaning that the
NPs are oxidized at their surface, as already reported for such
small sizes (24,31,37,41,42).
After co-precipitation, the stripped iron oxide NPcop is stable
in water suspension at pH below 5 or above 7 as the isoelectric
point (IEP) of NPcop is 6.8 (Fig. 3). The thermal decomposition
method leads to NPs covered with oleic acid in an organic solvant
(NPtd). The functionalization step was optimized to obtain stable
water suspensions of both iron oxide NPs. For NPcop, the direct
grafting by introducing molecules in NPcop water suspensions
was demonstrated to occur at pH 5 by interaction of negatively
charged phosphonate groups with hydroxyl and positively
charged groups at the iron oxide surface (30,31,43). The
hydrophilic oligoethyleneglycol-based dendron displaying a
phosphonic acid at the focal point was named ‘MOL’ and the
corresponding grafted nanoparticles NPcop@MOL. As observed
in Fig. 3, this grafting step induces a shift of the zeta potential
curve towards lower pH, leading thus to stable suspensions at
physiological pH. The particle size distribution in water of these
dendronized NPs is monomodal with an average particle size of
about 50 nm (Fig. 4). In order to improve this size distribution,
the functionalization process was optimized: the NPcop were
first coated with oleic acid and then transferred in hexane
(NPcop@AO). The particle size distribution in hexane, given in
Fig. 3, presents one peak with an average size of about 28 nm,
proving that this first step allows a decrease in the average
particle size in suspension. Then, a ligand exchange step with a
phase transfer in water was carried out through contact of
the NPcop@AO hexane suspension with a water suspension of
dendritic phosphonates (NPcop@MOL-LE). After such second
step, the particle size distribution was preserved with an average
particle size of about 30 nm. The zeta potential curve of
these grafted NPs also shifted towards lower pH as observed
for the directly grafted NPcop (Fig. 3).
The nanoparticles synthesized by thermal decomposition
(NPtd) are coated by oleic acid and form monodisperse and
stable suspension in hexane, as observed in Fig. 4. The average
particle size is around 13.8 nm, consistent with the diameter of
the NPs, taking into account the oleate coating. Then, the organic
grafting step also occurs by a ligand exchange and a phase
transfer process as for NPcop@OA: the resulting average particle
size is slightly increased (30 nm). The same shift of the zeta
potential curve to lower pH (Fig. 3) is also observed for these
NPtd@MOL, thus confirming the success of this grafting step.
All functionalized NPs (NPcop@MOL, NPcop@MOL-LE and
NPtd@MOL) were carefully characterized by XRD, thermogravi-
metric analyses (TGA), infra-red spectroscopy, transmission
electron microscopy and elemental analyses. Organic coating
was also confirmed by IR spectroscopy, showing the disappear-
ance of the P––O and P–OH bands as detailed in Basly et al. (30).
On the TGA curve recorded for NPcop, only a small weight
decrease was observed, resulting from the competition between
the oxidation of Fe2þ and the loss of adsorbed water. All grafted
NPs display a larger weight loss than non-grafted NPs, proving
the presence of organic molecules. However, the grafting rate
cannot be determined easily by these analyses due to a
competitive effect between the weight gain due to the oxidation
of Fe2þ and the weight loss due to dehydration and decompo-
sition of the dendritic shell. The grafting rate determined by
chemical analyses was shown to be similar for all grafted NPs and
equal to 1.2, 1.3 and 1.3 molecule/nm2 for NPcop@MOL,wileyonlinelibrary.com/journal/cmmi Copyright # 2010 John WilNPcop@MOL-LE and NPtd@MOL, respectively, thus very close
to the theoretical value of 1.4 molecule/nm2 for the whole
coverage of the NP surface. We calculated this theoretical value
by considering that the surface covered by one molecule is equal
to 0.75 nm2 (a value deduced from molecular modeling experi-
ments). The lattice parameters for all functionalized NPs slightly
decreased to ca 8.375 7 nm, showing that the grafting step
induced a slight oxidation of iron oxide NPs.
The magnetization curves of NPs before and after the grafting
step are given in Fig. 5. They are all characteristic of super-
paramagnetic nanoparticles and demonstrate that the magneticey & Sons, Ltd. Contrast Media Mol. Imaging 2011, 6 132–138
Figure 5. Magnetization curves of NPs synthesized by co-precipitation before and after direct functionalization (left) and of NPs synthesized by thermal
decomposition before and after functionalization by ligand exchange and phase transfer (right).
DENDRONIZED IRON OXIDE NANOPARTICLES FOR MRI APPLICATIONSproperties of all NPs are preserved after the grafting step. Indeed,
the saturation magnetization of the grafted NPcop after sub-
tracting the organic part is about 70 emu/g, a value slightly higher
than the one of the starting NPcop (65 emu/g). It is once
more demonstrated that phosphonate anchoring preserves the
magnetic properties of the iron oxide NPcop, certainly due to
super-super exchange interactions through the phosphonate
group (24). The magnetic properties of NPtd are also maintained
after the grafting step but the saturation magnetizations are
observed to be slightly lower than those of NPcop. Further
structural investigations are currently underway in our laboratory
to explain these different magnetic properties despite the
nanoparticle size being the same.
The ZFC/FC curves (Fig. 6) of NPtd before and after grafting are
also characteristic of superparamagnetic NPs and the maxima
of the ZFC curves may be ascribed to the blocking temperature
Tb, which marks the transition from superparamagnetism to
ferrimagnetism. The blocking temperature of nanoparticles
synthesized by thermal decomposition and coated with oleic
acid is around 130 K, consistent with the reported Tb for such size
and synthetic method (34,38). After organic coating, a slight shift
in Tb is observed, but the ZFC peak is broader with NPtd@OA than
with NPtd@MOL, suggesting a distribution of Tb in the NPtd@OA
case. This slight shift in Tb towards lower temperature for
NPtd@MOL may be attributed either to a modification of the
magnetocristalline anisotropy due to the phosphonate graftingFigure 6. ZFC/FC curves of NPs synthesized by co-precipitation before an
decomposition before and after functionalization by ligand exchange and p
Contrast Media Mol. Imaging 2011, 6 132–138 Copyright # 2010 Johor to weaker dipolar interactions due to the organic coating
inducing larger interparticle distances.
The NPs synthesized by coprecipitation display very broad ZFC
peaks and the blocking temperature is above 300K (Fig. 6). The
aggregation state of NPcop probably induces strong dipolar
interactions between NPs and thus a Tb shift towards higher
values. When the nanoparticles are coated with the dendritic
phosphonates, the ZFC peak maximum is 250 K and, as discussed
above, the origin of this shift needs further and deeper
characterizations (ACmeasurements and Mo¨ssbauer spectroscopy)
to discriminate clearly between surface effect and dipolar
interactions. However this shift is consistent with a disaggrega-
tion of NPcop after the indirect functionalization process. Indeed
one may only underline that, the higher the aggregation state in
suspension, the higher the Tb value.
Finally, the relaxation properties of the colloidal suspensions
were studied in order to evaluate the possible use of these
materials as MRI contrast agents. The effectiveness of contrast
agents is usually expressed in term of relaxivities, r1 and r2, per
millimolar concentration of metal. From in vitro relaxivity studies
at 1.5 T and at room temperature, values as high as 234mM1 s1
for r2, 10mM
1 s1 for r1, and an r2/r1 ratio 25 were obtained for
NPcop@MOL with the highest hydrodynamic particle size
(Table 1). These values decreased slightly with the particle size,
as observed for NPcop@MOL-LE. Such an evolution is consistent
with a decrease in the agglomeration state of NPcop (43), but oned after direct functionalization (left) and of NPs synthesized by thermal
hase transfer (right).
n Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/cmmi
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Table 1. In vitro relaxivity studies (1.5 T, 37 8C) of dendronized NPs compared to some commercial or under clinical investigation
products (18)
Name of the compound
(company) Coating agent
Hydrodynamic
Size (nm)
r1
(mM1  s1)
r2
(mM1  s1) r2/r1
Abdoscan (Ferropharm) Citrate 7 14 33.4 2.4
Supravist (Schering) Carboxydextran 21 10.7 38 3.6
Sinerem (Guerbet) Dextran T10, T1 15–30 9,9 65 6.7
Ferumoxytol (Adv.
Magnetics)
Carboxymethyl-dextran T10 30 15 89 5.9
Resovist (Schering) Carboxydextran 60 9.7 189 19.5
Endorem (Guerbet) Dextran T10 120–180 10.1 120 11.9
Our study (Coll. P. Perriat, Lyon)
Endorem (Guerbet) Dextran T10 120–180 10.6 141 13.2
Our samples TD NPtd@MOL 30 10.4 130 12.5
COP NPcop@MOL-LE 30 8.5 160 18.8
NPcop@MOL 50 10 234 24.9
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6may notice that both the r2 value and the r2/r1 ratio are among
the highest reported for commercial polymer-decorated nano-
particles. Despite similar average hydrodynamic sizes, relaxivity
values are lower for NPtd@MOL and may be related to the lower
saturation magnetization of these NPs. Nevertheless, one may
not conclude clearly on the effect of aggregation for both
these powders as the observed Tb shift in ZFC curves may also be
the consequence of a modification of the surface properties after
the grafting step.3. Conclusion
Iron oxide nanoparticles with sizes around 10 nm were syn-
thesized by two methods: the co-precipitation of iron chlorides
by a base and the thermal decomposition of an iron stearate
complex. The NPs synthesized by thermal decomposition
were functionalized by a biocompatible dendritic phosphonate
through a ligand exchange and phase transfer process. The size
distribution in water suspension of NPs synthesized by coprecipi-
tation has been improved by a two-step process involving coating
of NPs with oleic acid and then a ligand exchange and phase
transfer step. The magnetic properties are essentially preserved
after the functionalization step but the saturation magnetization
of NPcop was observed to be higher than that of NPtd. All
functionalized NPs display high relaxivity values by comparison
with commercial polymer-coated nanoparticles. The higher
relaxivity value of NPcop obtained through direct functionaliza-
tion is probably related to their aggregation state and the lower
value for functionalized NPtd is mainly related to their lower
saturation magnetization. However, further studies dealing with
the effect of the grafting step on the surface and magnetic
properties (AC measurements) are currently underway. In order
to improve the colloidal stability of these dendronized nano-
particles, higher generation dendrons as well as charged
dendrons bearing either carboxylic acid or amine groups
will be grafted at the surface of nanometer size NPs. Finally,
functionalization of the dendron periphery by fluorescent or
targeting molecules is also envisaged.wileyonlinelibrary.com/journal/cmmi Copyright # 2010 John Wil4. Experimental
4.1. Synthesis of NPs
4.1.1. NPcop
Distilled water degassed with argon for half an hour was used for
the preparation of 1 M FeCl36H2O and 2 M FeCl

24H2O by dissolving
iron salts in 2 M HCl solutions. A 10ml aliquot of a 1 M FeCl3
solution was mixed with 2.5ml of a 2 M FeCl2 solution. The
so-obtained mixture was stirred and heated up to 70 8C while
kept under argon before slow addition of 21ml of a 25% aqueous
solution of N(CH3)4OH. Vigorous stirring was maintained for
20min. The solution color changed from orange to black, leading
to a black precipitate, and the suspension was slowly cooled
to room temperature. The powder thus obtained was washed
several times by magnetic decantation in water.
4.1.2. NPtd
A 1.38 g (2.22 103 mol) aliquot of Fe(stearate)2 and 1.25 g
(4.44 103 mol) of oleic acid (99%, Alfa-Aesar) were added to
20ml octyl ether (97%, Fluka, b.p. 287 8C). The mixture was
kept under vigorous stirring for 1 h to dissolve the reactants. The
solution was heated to 287 8C with a heating rate of 5 8C/min
without stirring and was refluxed for 120min at this temperature
under air. The resultant black solution was then cooled down to
room temperature and the NPs were washed three times by
addition of ethanol and by centrifugation (8000 rpm, 10min). The
NPs were then easily suspended in hexane.
4.2. Functionalization process
4.2.1. NPcop
Direct grafting: grafting of dendritic phosphonate in water at
the surface of NPcop has been demonstrated to be favored by
electrostatic interactions (30,42). Therefore, it must be performed
in a pH range determined by the pKa values of the dendritic
phosphonate (3 and 5–6; the pH must be above 3) and by the
isoelectric point (IEP) value of bare NPcop, which is 6.8 (pH must
be lower than 6.8): thus, the chosen compromise was pH 5 (30). Toey & Sons, Ltd. Contrast Media Mol. Imaging 2011, 6 132–138
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1achieve this, 50mg of nanoparticles were added to 40mg of
dendron dissolved in 50ml of degassed water (pH¼ 3). Then
N(CH3)4OH was added in order to reach a pH value of 5. The
suspension was sonicated in a standard/laboratory sonicator
(Transsonic 275/H Prolabo) for 90min at 35 8C and the grafted
NPs were separated from the ungrafted molecules by ultrafiltra-
tion. This technique uses regenerated cellulose membranes
with a nominal molecular weight limit (NMWL) of 3 kDa. A 25ml
aliquot of the water suspension was introduced in the apparatus
and ultrafiltration (purification) occurred by pressurizing the
solution flow. The solvent and ungraftedmolecules went through
the membrane. The grafted nanoparticles, which did not pass
through, were redispersed in 25ml of water and submitted to
another ultrafiltration step. This was done five times. After such
purification step, the pH of the NPs suspension was around 6.
Such grafted NPs were named NPcop@MOL.
The process involved two ligand exchange steps: 4.9mg
(1.735 105 mol) of oleic acid (99%, Alfa-Aesar) was added to
5ml of a water suspension of NPcop (33mg/ml) at pH¼ 11.
Then pH was adjusted to a value of 3.5 by adding HCl. Oleic
acid interacted with the surface of NPcop and, owing to this
hydrophobic coating, decorated NPs precipitated and were
separated from the water suspension. The black precipitate was
washed three times by addition of water and decantation, and
three times by addition of ethanol and magnetic decantation.
The so-obtained grafted nanoparticles were named NPcop@OA.
The NPcop@OA were transferred in hexane (1mg/ml) and
10ml of this suspension was put into contact with a water
suspension of the dendritic phosphonate at pH¼ 4 (13mg of
molecules, 5ml of water and 2ml of methanol). Both immiscible
suspensions were magnetically stirred for one night. A ligand
exchange and a phase transfer in water occurred and a water
suspension of NPcop was thus obtained. After a purification step
by ultrafiltration, the pH of the NPs suspension was around 6.
The grafted nanoparticles thus obtained were named NPcop@-
MOL-LE.
4.2.2. NPtd
A 10ml aliquot of a suspension of NPtd@OA in hexane (1mg/ml)
was put into contact with a water suspension of the dendritic
phosphonate at pH¼ 4 (13mg of molecules, 5ml of water and
2ml of methanol). Both immiscible suspensions were magneti-
cally stirred for one night. A ligand exchange and a phase transfer
in water occurred and a water suspension of NPtd was thus
obtained. After purification steps by ultrafiltration, the pH of the
NPs suspension was around 6. The grafted nanoparticles thus
obtained were named NPtd@MOL.
4.3. Characterization techniques
The NPs before and after grafting were characterized by
X-ray diffraction (XRD) using a Bruker D8 Advance equipped
with a monochromatic copper radiation (Ka¼ 0.154056 nm),
by transmission electron microscopy with a TOPCON 002B
microscope operating at 200 kV (point resolution 0.18 nm) and
equipped with a GATAN GIF 200 electron imaging filter.
The grafting step was confirmed by thermogravimetric mea-
surements under air using a TA Instrument apparatus with a
heating rate of 5 8C/min and by infra red spectroscopy using
a Fourier transform infrared spectrometer (Digilab FTS 3000;Contrast Media Mol. Imaging 2011, 6 132–138 Copyright # 2010 Johsamples were gently ground and diluted in non-absorbent KBr
matrices).
The grafting rate was determined by chemical analyses.
In previous studies, the grafting rate on NPcop was determined
indirectly by UV spectroscopy (evaluation of the amount of
ungrafted molecules in washing solutions) and directly by
chemical analyses of the dendritic hybrids. Both methods gave
similar results.
Hysteresis cycles of the NPs and the grafted NPs were recorded
at room temperature using a Foner EG&G model 155 vibrating
sample magnetometer and ZFC/FC measurements were per-
formed with a Superconducting Quantum Interference Device
(Squid) magnetometer (Quantum Design MPMS-XL model)
between 5 and 300 K under a field of 75 G.Acknowledgements
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